Viewing Study NCT02868905


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2026-03-01 @ 4:13 PM
Study NCT ID: NCT02868905
Status: UNKNOWN
Last Update Posted: 2016-08-16
First Post: 2016-08-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women
Sponsor: Central Hospital, Nancy, France
Organization:

Study Overview

Official Title: Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women - Pilot Study
Status: UNKNOWN
Status Verified Date: 2016-08
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Oba
Brief Summary: The purpose of this study is to compare average methylation of epigenetic markers on genomic DNA and some genes (APP, BACE, LRP, SorL1) involved in cerebral amyloid homeostasis:

* Of obese young adults and healthy young adults
* Of obese young adults and individuals affected by Alzheimer's disease (AD) having been obese at young adult age (\<50 years old) or individuals affected by Alzheimer's disease (AD) having never been obese.

The secondary purpose is to determine if there is an association between the frequency of these epigenetic markers and elements associated to the metabolic syndrome (lipidic and glycemic analysis, leptinemia, inflammation markers) and clinical ones (visceral fat mass, body mass index) in young adults.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: